scholarly article | Q13442814 |
P819 | ADS bibcode | 1991PNAS...88.4855F |
P356 | DOI | 10.1073/PNAS.88.11.4855 |
P932 | PMC publication ID | 51765 |
P698 | PubMed publication ID | 2052566 |
P5875 | ResearchGate publication ID | 21102595 |
P2093 | author name string | J J Albers | |
P H Pritchard | |||
G Assmann | |||
H Funke | |||
J J Kastelein | |||
A von Eckardstein | |||
C Droste | |||
P2860 | cites work | Designed diagnostic restriction fragment length polymorphisms for the detection of point mutations in ras oncogenes | Q69371372 |
Human plasma lecithin-cholesterol acyltransferase. An elucidation of the catalytic mechanism | Q69491747 | ||
Early incorporation of cell-derived cholesterol into pre-beta-migrating high-density lipoprotein | Q70380516 | ||
Human plasma lecithin-cholesterol acyltransferase. The vicinal nature of cysteine 31 and cysteine 184 in the catalytic site | Q70385758 | ||
Characterization of proteoliposomes containing apoprotein A-I: a new substrate for the measurement of lecithin: cholesterol acyltransferase activity | Q71620292 | ||
Human lecithin-cholesterol acyltransferase gene: complete gene sequence and sites of expression | Q24609462 | ||
Enzymatic amplification of beta-globin genomic sequences and restriction site analysis for diagnosis of sickle cell anemia | Q27861076 | ||
Lecithin:cholesterol acyltransferase. Functional regions and a structural model of the enzyme | Q28282788 | ||
Evaluation of methods for the measurement of low-density lipoprotein cholesterol. | Q29547378 | ||
A frameshift mutation in the human apolipoprotein A-I gene causes high density lipoprotein deficiency, partial lecithin: cholesterol-acyltransferase deficiency, and corneal opacities | Q33382898 | ||
Generation of single-stranded DNA by the polymerase chain reaction and its application to direct sequencing of the HLA-DQA locus | Q33655616 | ||
Single bilayer liposomes prepared without sonication | Q34217773 | ||
DNA inversion within the apolipoproteins AI/CIII/AIV-encoding gene cluster of certain patients with premature atherosclerosis | Q34353981 | ||
Cholesterol net transport, esterification, and transfer in human hyperlipidemic plasma | Q35203780 | ||
Lymphocyte reactivity in patients with carcinoma of the breast and large bowel | Q36068057 | ||
Radioimmunoassay of human plasma lecithin-cholesterol acyltransferase | Q37025738 | ||
High-density lipoprotein--the clinical implications of recent studies | Q38700033 | ||
Cyclic A.M.P. and arrhythmias revisited | Q39515694 | ||
Lecithin: cholesterol acyltransferase and the regulation of endogenous cholesterol transport. | Q40211043 | ||
Evidence for the presence in human plasma of lecithin: cholesterol acyltransferase activity (beta-LCAT) specifically esterifying free cholesterol of combined pre-beta- and beta-lipoproteins. Studies of fish eye disease patients and control subjects | Q41505971 | ||
Mechanism of transfer of LDL-derived free cholesterol to HDL subfractions in human plasma | Q46268227 | ||
Paradoxical esterification of plasma cholesterol in fish eye disease. | Q49186721 | ||
Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. | Q51679983 | ||
Simplified turbidimetric determination of apolipoproteins A-I, A-II and B using a microtitre method | Q67244244 | ||
Hypoalphalipoproteinemia resembling fish eye disease | Q69047587 | ||
Familial apolipoprotein A-I, C-III, and A-IV deficiency and premature atherosclerosis due to deletion of a gene complex on chromosome 11 | Q69231380 | ||
P433 | issue | 11 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | eye disease | Q3041498 |
P304 | page(s) | 4855-9 | |
P577 | publication date | 1991-06-01 | |
P1433 | published in | Proceedings of the National Academy of Sciences of the United States of America | Q1146531 |
P1476 | title | A molecular defect causing fish eye disease: an amino acid exchange in lecithin-cholesterol acyltransferase (LCAT) leads to the selective loss of alpha-LCAT activity | |
P478 | volume | 88 |
Q63979951 | A molecular approach to inherited kidney disorders |
Q36387268 | A physiologically based in silico kinetic model predicting plasma cholesterol concentrations in humans |
Q24336518 | A plasma lipoprotein containing only apolipoprotein E and with gamma mobility on electrophoresis releases cholesterol from cells |
Q47655146 | A retractable lid in lecithin:cholesterol acyltransferase provides a structural mechanism for activation by apolipoprotein A-I. |
Q34386276 | A unique genetic and biochemical presentation of fish-eye disease |
Q39812837 | An apoA-I mimetic peptide increases LCAT activity in mice through increasing HDL concentration |
Q37357561 | An intronic mutation in a lariat branchpoint sequence is a direct cause of an inherited human disorder (fish-eye disease). |
Q35797202 | Analysis of familial hypoalphalipoproteinemia syndromes |
Q40716232 | Analysis of glomerulosclerosis and atherosclerosis in lecithin cholesterol acyltransferase-deficient mice. |
Q73129821 | Analysis of human lecithin-cholesterol acyltransferase activity by carboxyl-terminal truncation |
Q35370268 | ApoE regulates hematopoietic stem cell proliferation, monocytosis, and monocyte accumulation in atherosclerotic lesions in mice |
Q34119817 | Apolipoprotein A-I Q[-2]X causing isolated apolipoprotein A-I deficiency in a family with analphalipoproteinemia |
Q77220547 | Assignment of Tangier disease to chromosome 9q31 by a graphical linkage exclusion strategy |
Q33890253 | Characterization of apolipoprotein A-I- and A-II-containing lipoproteins in a new case of high density lipoprotein deficiency resembling Tangier disease and their effects on intracellular cholesterol efflux |
Q48069326 | Chicken lecithin-cholesterol acyltransferase. Molecular characterization reveals unusual structure and expression pattern |
Q72992419 | Classical LCAT deficiency resulting from a novel homozygous dinucleotide deletion in exon 4 of the human lecithin: cholesterol acyltransferase gene causing a frameshift and stop codon at residue 144 |
Q34362195 | Clinical and histopathological features of a suspected case of fish-eye disease |
Q24598765 | Common variants at 30 loci contribute to polygenic dyslipidemia |
Q44361735 | Deletion of N-terminal amino acids from human lecithin:cholesterol acyltransferase differentially affects enzyme activity toward alpha- and beta-substrate lipoproteins |
Q82443808 | Disturbed apolipoprotein A-I-containing lipoproteins in fish-eye disease are improved by the lecithin:cholesterol acyltransferase produced by gene-transduced adipocytes in vitro |
Q41962268 | Familial lecithin-cholesterol acyltransferase (LCAT) deficiency; a differential of proteinuria |
Q34114305 | Fish eye syndrome: a molecular defect in the lecithin-cholesterol acyltransferase (LCAT) gene associated with normal alpha-LCAT-specific activity. Implications for classification and prognosis |
Q33891534 | Genetic and phenotypic heterogeneity in familial lecithin: cholesterol acyltransferase (LCAT) deficiency. Six newly identified defective alleles further contribute to the structural heterogeneity in this disease |
Q40266047 | Genetics of corneal disease for the ocular surface clinician. |
Q34869723 | Genome-wide single-nucleotide polymorphism analysis defines haplotype patterns in mouse |
Q38197735 | HDL quality and functionality: what can proteins and genes predict? |
Q36766976 | High density lipoprotein cholesterol: an evolving target of therapy in the management of cardiovascular disease |
Q30406862 | High prevalence of mutations in LCAT in patients with low HDL cholesterol levels in The Netherlands: identification and characterization of eight novel mutations |
Q52509864 | In vitro expression of structural defects in the lecithin-cholesterol acyltransferase gene. |
Q34021570 | Lecithin: cholesterol acyltransferase--from biochemistry to role in cardiovascular disease |
Q43719479 | Lecithin:cholesterol acyl transferase G30S: association with atherosclerosis, hypoalphalipoproteinemia and reduced in vivo enzyme activity |
Q36723319 | Lipid oxidation in carriers of lecithin:cholesterol acyltransferase gene mutations |
Q47788413 | Lipid-free apolipoprotein (apo) A-I is converted into alpha-migrating high density lipoproteins by lipoprotein-depleted plasma of normolipidemic donors and apo A-I-deficient patients but not of Tangier disease patients |
Q37544267 | Lipoproteins, cholesterol homeostasis and cardiac health |
Q35665689 | Mapping the eye diseases |
Q34120460 | Markedly accelerated catabolism of apolipoprotein A-II (ApoA-II) and high density lipoproteins containing ApoA-II in classic lecithin: cholesterol acyltransferase deficiency and fish-eye disease |
Q40836393 | Molecular diagnostics for cardiovascular disease |
Q24670184 | Nonsynonymous polymorphic sites in the apolipoprotein (apo) A-IV gene are associated with changes in the concentration of apo B- and apo A-I-containing lipoproteins in a normal population |
Q33791444 | Remodeling adipose tissue through in silico modulation of fat storage for the prevention of type 2 diabetes. |
Q34404589 | Segregation of LIPG, CETP, and GALNT2 mutations in Caucasian families with extremely high HDL cholesterol |
Q28626773 | Structural and functional properties of two mutants of lecithin-cholesterol acyltransferase (T123I and N228K) |
Q41041206 | T-->G or T-->A mutation introduced in the branchpoint consensus sequence of intron 4 of lecithin:cholesterol acyltransferase (LCAT) gene: intron retention causing LCAT deficiency |
Q28263895 | The genetic defect of the original Norwegian lecithin:cholesterol acyltransferase deficiency families |
Q53750486 | The low down on lipoprotein lipase. |
Q36307357 | The use of PCR in diagnosing lipoprotein disorders |
Q24564900 | Two different allelic mutations in the lecithin-cholesterol acyltransferase gene associated with the fish eye syndrome. Lecithin-cholesterol acyltransferase (Thr123----Ile) and lecithin-cholesterol acyltransferase (Thr347----Met) |
Search more.